Details of the Drug

General Information of Drug (ID: DMW8C1D)

• Drug Name: ADXS-HER2
• Synonyms: Lovaxin B; ADXS31-164; Her2/neu cancer vaccine (Listeria vector), Advaxis

Indication

Disease Entry	ICD 11	Status	REF
Solid tumour/cancer	2A00-2F9Z	Phase 2	[1]
Breast cancer	2C60-2C65	Phase 1/2	[2]

• Cross-matching ID: TTD ID: D06UEC
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
• [2] ClinicalTrials.gov (NCT02386501) Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors. U.S. National Institutes of Health.